Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases
Clinical trial NCT03967522 · COMPLETED
Trial details
- NCT number
- NCT03967522
- Sponsor
- Centre Leon Berard
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-29
- Primary completion
- 2024-10-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.